Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-05

Clinical Trial Update: taVNS or TMS or Both for Depression [NA]

View source ↗

Summary

This update indicates that a study is recruiting to assess taVNS or transcranial magnetic stimulation (TMS), alone or in combination, for depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TMS (Transcranial magnetic stimulation)
  • taVNS (transcutaneous auricular vagus nerve stimulation)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Depression | NA | Status: RECRUITING